The increasing burden of chronic diseases and growing elderly population worldwide are also expected to drive the adoption of advanced endoscopy tools such as wireless capsule endoscopy and high-resolution cameras use in the coming years. Gallstones, endometriosis, and bowel perforation require endoscopic interventions, which was expected to drive the endoscopy devices market in forecast years.
Additionally, medical professionals who want to use advanced endoscopic technology equipped with high resolution camera light to help physicians create internal organs of interest about such as, Stryker, Olympus Corporation, Fujifilm Holdings Corporation analyses in premium cameras are also driving the market. A change in preference for minimally invasive surgery over conventional surgery to reduce postoperative complications and reduce hospital stays are key factors expected if endoscopic devices demand has increased, which will accelerate Endoscopy Devices Market growth.
Endoscopy Devices Market size was valued at USD 25.2 billion in 2023 and is poised to grow from USD 26.99 billion in 2024 to USD 46.72 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).
The increasing global burden of cancer also drives the adoption of diagnostic devices for early diagnosis and treatment. Furthermore, the increasing preference for biopsy for cancer detection and diagnosis in recent years is also likely to drive the adoption of endoscopic devices, which in turn is expected to drive the development of endoscopic devices over the years.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/endoscopy-devices-market
Endoscopy Devices Market – Regional Analysis:
North America dominated the endoscopy devices market in 2023, accounting for the largest revenue share at 41.0%. The high prevalence of many diseases, including gastrointestinal disorders, respiratory conditions, neurological problems, gynecological issues, and cancer, creates the need for endoscopic techniques for diagnosis and treatment disease.
Asia Pacific is expected to be the fastest growing region in the Endoscopy Devices Market owing to rapidly developing healthcare, less stringent regulatory framework and economic growth that attracts foreign investment. The market is expected to grow owing to good initiatives by private players, such as training of healthcare professionals and increased investment in R&D to develop moving endoscopes. China’s endoscopy devices market accounted for the largest share in 2023. China has the largest population in the world and is one of the fastest growing economies.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Endoscopy Devices Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Endoscopy Devices Market is segmented by Product, Application, Hygiene, End-Use and region.
Based on Product, the market is segmented into Endoscopes, Endoscopy Visualization Systems, Endoscopy Visualization Components and Operative Devices.
Based on Application, the market is segmented into Urology Endoscopy, Gastrointestinal (GI) Endoscopy, Obstetrics Endoscopy, Laryngoscopy, Laparoscopy, Bronchoscopy, Arthroscopy, Otoscopy, Mediastinoscopy and Other Applications.
Based on Hygiene, the market is segmented into Single-Use, Reprocessing and Sterilization.
Based on End-Use, the market is segmented into Ambulatory Surgical Centers, Hospitals and Other End-uses.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Top Market Players in Endoscopy Devices Market are:
Medtronic (US)
Johnson & Johnson (US)
Olympus Corporation (Japan)
Fujifilm Holdings Corporation (Japan)
Stryker Corporation (US)
Karl Storz SE & Co. KG (Germany)
Boston Scientific Corporation (US)
Cook Medical (US)
Smith & Nephew plc (UK)
Hoya Corporation (Japan)
CONMED Corporation (US)
Pentax Medical (Japan)
Richard Wolf GmbH (Germany)
B. Braun Melsungen AG (Germany)
Olympus Medical Systems Corp. (Japan)
Fujifilm Medical Systems USA, Inc. (US)
Medtronic plc (Ireland)
KARL STORZ Endoscopy-America, Inc. (US)
Arthrex, Inc. (US)
Ethicon, Inc. (US)
Global Endoscopy Devices Market Recent Developments:
In March 2023, AIG Hospitals in Hyderabad established a Center of Excellence (CoE) in collaboration with Boston Science Club. The collaboration aims to enhance healthcare delivery by providing advanced treatment options and expertise in various medical fields. The CoE will focus on cardiology, gastroenterology, urology, & endoscopy, utilizing Boston Scientific’s innovative medical technologies and AIG Hospitals’ commitment to providing superior patient care. The partnership between AIG Hospitals and Boston Scientific is expected to bring significant growth and development for patients in Hyderabad & surrounding areas.
In August 2024, Ambu received CE marking approval for its new generation duodenoscopy solutions, Ambu Abox 2 and Ambu Ascope Duodeno 2, for ERCP procedures.
In November 2023, Ambu obtained 510(k) regulatory authorization from the US. FDA there for its urine guidance solutions, which include the aScope 5 Uretero (single-use urine guidance), aBox 2, and a complete HD endoscopy system.
In February 2022, Medtronic partnered with the American Society of Gastroenterology (ASGE) to provide AI-powered colonoscopy technology for colorectal cancer screening in the US.
You may Also Like
https://www.linkedin.com/pulse/global-mice-market-trends-growth-drivers-future-outlook-trivedi-9nbyc/ – Mice Market
https://vinitsawant.hatenablog.com/entry/2025/04/22/215955 – Organ on Chip Market
Forward-Looking Insights
The Endoscopy Devices Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
